Summary
Since 1978 we have taken an interest in lower respiratory tract infections associated with Branhamella catarrhalis in Christchurch, New Zealand. In a preliminary trial, 20 patients with bronchopulmonary infection caused by β-lactamase-producing B. catarrhalis were treated with a combination tablet of amoxycillin 500mg and clavulanic acid 125mg (‘Augmentin’) 3 times daily for 5 days. Sputum cultures were negative for B. catarrhalis within 3 days in all patients. Two of 7 patients whose sputum cultures were positive for this organism at a review 2 to 4 weeks later were successfully treated with a further course of amoxycillin/clavulanic acid.
Similar content being viewed by others
References
Aitken JM, Thornley PE. Isolation of Branhamella catarrhalis from sputum and tracheal aspirate. Journal of Clinical Microbiology 18: 1262–1263, 1983
Ninane G, Joly J, Kraytman M. Bronchopulmonary infection due to Branhamella catarrhalis: 11 cases assessed by transtracheal puncture. British Medical Journal 1: 276–278, 1978
Slevin NJ, Aitken J, Thornley PE. Clinical and microbiological features of Branhamella catarrhalis bronchopulmonary infections. Lancet 1: 782–783, 1984
Thornley PE, Aitken J, Drennan CJ, MacVicar J, Slevin NJ. Branhamella catarrhalis infection of the lower respiratory tract: reliable diagnosis by sputum examination. British Medical Journal 1: 1537–1538, 1982
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Thornley, P.E., Aitken, J.M., Nichol, G.M. et al. Amoxycillin-Clavulanic Acid Combination in Bronchopulmonary Infection due to β-Lactamase-producing Branhamella catarrhalis . Drugs 31 (Suppl 3), 113–114 (1986). https://doi.org/10.2165/00003495-198600313-00024
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198600313-00024